Venetoclax: evidence to date and clinical potential

The emergence of targeted therapy for patients with hematological diseases has permanently altered the therapeutic landscape. Immunochemotherapy regimes are now more and more being replaced by targeted therapies due to superior efficacy and better safety profiles. However, evolution and selection of...

Full description

Bibliographic Details
Main Authors: Luis Miguel Juárez-Salcedo, Viraj Desai, Samir Dalia
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2019-10-01
Series:Drugs in Context
Subjects:
Online Access:https://www.drugsincontext.com/venetoclax:-evidence-to-date-and-clinical-potential/